BRD4 and acute lymphoblastic leukemia: King et al. demonstrated that treatment with BET inhibitors repressed MYC protein expression and arrested leukemia cell growth in T-ALL cell lines, a result consistent with the one obtained by the genetic abrogation of MYC and BRD4 in NOTCH1-positive T-ALL [140].